Home
About
Services
Partners
Client Portfolio
News
Contact
Mexico, U.S. seek to dispel tension over labor tweak to trade deal
December 16, 2019
Amazon blocks sellers from using FedEx for some Prime shipments
December 17, 2019
0
U.S. approves Roche’s $4.3 billion purchase of Spark Therapeutics
Published by
Muller&Green
at
December 16, 2019
Categories
RSS
Tags
Swiss drugmaker Roche has won U.S. antitrust approval for its $4.3 billion deal to buy gene therapy specialist Spark Therapeutics clearing the way for Roche’s push into treating rare diseases including hemophilia A.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more